Evidence map›Paper›PMID 35501382›Full record

ArticleNature neuroscience2022

Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis.

Fadi E Pulous, Jean C Cruz-Hernández, Chongbo Yang, Ζeynep Kaya, Alexandre Paccalet, Gregory Wojtkiewicz, Diane Capen, Dennis Brown, Juwell W Wu, Maximilian J Schloss and 15 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05849805 nacompletednot on this mapstarted 2023, after this paper: background citation

The Feasibility, Safety and Efficacy of Y-3 Injection Through Skull Bone Marrow Bypassing Blood-brain Barrier in the Treatment of Acute Malignant Middle Cerebral Artery Infarction(SOLUTION)

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2024Enrolled20ConditionsStroke, Acute IschemicArmsIntracalvaria bone marrow injection, Conventional treatment
NCT07514949 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device

TypeinterventionalSponsoryilong WangRan2026 to 2026Enrolled6ConditionsStroke, Acute Ischemic Stroke, Blood-Brain BarrierArmsRK-4 ICO injection, Conventional treatment
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 176 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Expanding roles of cGAS-STING signaling in neuroinflammation.The Journal of clinical investigation · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 3 countries.

Fadi E Pulous *Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-0794-8078
Jean C Cruz-Hernández *Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Chongbo YangCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ζeynep KayaCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Alexandre PaccaletCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6331-562X
Gregory WojtkiewiczCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3148-8411
Diane CapenProgram in Membrane Biology, Division of Nephrology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
Dennis BrownProgram in Membrane Biology, Division of Nephrology, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
Juwell W WuCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Maximilian J SchlossCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Claudio VinegoniCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9818-3639
Dmitry RichterCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Masahiro YamazoeCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Maarten HulsmansCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1009-658X
Noor MominCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jana GruneCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
David RohdeCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3785-9375
Cameron S McAlpineCardiovascular Research Institute and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Peter PanizziDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Dong-Eog KimMolecular Imaging and Neurovascular Research Laboratory, Department of Neurology, Dongguk University College of Medicine, Goyang, South Korea.
Filip K SwirskiCardiovascular Research Institute and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3163-9152
Charles P LinCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. charles_lin@hms.harvard.edu.ORCID 0000-0002-7450-627X
Michael A MoskowitzCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. moskowitz@helix.mgh.harvard.edu.ORCID 0000-0002-9052-4937
Matthias NahrendorfCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. mnahrendorf@mgh.harvard.edu.ORCID 0000-0002-4021-1887
Harvard University · USIcahn School of Medicine at Mount Sinai · USAuburn University · USDongguk University · KR

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
PROJECT 4: Somatic evolution of the hematopoietic system in cardiovascular diseaseP01HL142494 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Filip K Swirski · 2019 to 2026
$19.5M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
Imaging organ system interfaces in ischemic heart diseaseR35HL139598 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS · 2018 to 2024
$6.9M
Macrophages in homeostasis and cardiovascular diseaseR35HL135752 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SWIRSKI, FILIP K · 2017 to 2023
$5.4M
P&F programP30DK135043 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Deborah J Wexler · 2023 to 2026
$5.4M
Skull marrow crosstalk with the central nervous systemR01NS108419 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSKOWITZ, MICHAEL A., NAHRENDORF, MATTHIAS · 2018 to 2022
$3.4M
Influence of sleep on the hematopoietic niche and atherosclerosis during agingR01HL158534 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MCALPINE, CAMERON STUART · 2021 to 2025
$2.1M
Interfering with the macrophage life cycle of atherosclerosisR01HL125428 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, DANIEL G, NAHRENDORF, MATTHIAS · 2017 to 2020
$1.9M
Influence of sleep on hematopoietic stem cell diversity and clonality in cardiovascular diseaseR00HL151750 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MCALPINE, CAMERON STUART · 2021 to 2023
$747k
Bone Marrow Endothelial VEGFR3 Regulation of Leukocyte Trafficking in Myocardial InfarctionF32HL158040 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI PULOUS, FADI EMAD · 2021 to 2023
$121k
NCI NIH HHS T32 CA079443NHLBI NIH HHS F32 HL158040NHLBI NIH HHS P01 HL142494NHLBI NIH HHS R00 HL151750NHLBI NIH HHS R01 HL125428NHLBI NIH HHS R01 HL158534NHLBI NIH HHS R35 HL135752NHLBI NIH HHS R35 HL139598NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK135043NINDS NIH HHS R01 NS108419
6 · The paper itself

Abstract

Interactions between the immune and central nervous systems strongly influence brain health. Although the blood-brain barrier restricts this crosstalk, we now know that meningeal gateways through brain border tissues facilitate intersystem communication. Cerebrospinal fluid (CSF), which interfaces with the glymphatic system and thereby drains the brain's interstitial and perivascular spaces, facilitates outward signaling beyond the blood-brain barrier. In the present study, we report that CSF can exit into the skull bone marrow. Fluorescent tracers injected into the cisterna magna of mice migrate along perivascular spaces of dural blood vessels and then travel through hundreds of sub-millimeter skull channels into the calvarial marrow. During meningitis, bacteria hijack this route to invade the skull's hematopoietic niches and initiate cranial hematopoiesis ahead of remote tibial sites. As skull channels also directly provide leukocytes to meninges, the privileged sampling of brain-derived danger signals in CSF by regional marrow may have broad implications for inflammatory neurological disorders.

Indexed as

Glymphatic SystemMeningitis, BacterialAnimalsBone MarrowBrainCerebrospinal FluidHematopoiesisMiceSkull

Identifiers

PMID35501382
PMCPMC9081225
OpenAlexW4225270967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.